Home Therapy in Minnesota

Fiix Body manufactures the Fiix Elbow, an FDA-registered Class I medical device designed for at-home treatment of tennis elbow (lateral epicondylitis) and golfer's elbow (medial epicondylitis). The device automates a clinically proven deep tissue scraping therapy that breaks down scar tissue and adhesions in the tendon and surrounding connective tissue. Founded by physical therapists Nate Stier PT, LAT, ATC and Rusty Wallman PT, ATC (both Mayo Clinic graduates), along with an entrepreneurial co-founder, Fiix Body addresses the compliance challenge in physical therapy by bringing treatment directly to patients. The Fiix Elbow uses patented linear massage technology requiring only 10 minutes of use, 3 times per week, paired with a mobile app for guided instructions, progress tracking, and daily exercise recommendations. Treatment duration is typically 8 weeks. The company offers both purchase and rental options, and the device is eligible for reimbursement via FSA/HSA funds. Clinical outcomes reported include 96% success rate, with endorsements from sports medicine physicians and professional athletes. The device is designed for active individuals who wish to continue lifting, playing sports, or working during the healing process, without complete rest.

Tactile Medical is a medical device manufacturer specializing in pneumatic compression therapy systems and airway clearance devices for home and clinical use. The company develops FDA-cleared products for lymphedema management and chronic respiratory conditions. Primary product lines include the Flexitouch Plus system for pneumatic compression therapy across upper body, lower body, and head/neck applications; the Nimbl portable pneumatic compression device designed for improved patient mobility and convenience; and AffloVest, a high-frequency chest wall oscillation (HFCWO) therapy system for airway clearance in patients with chronic respiratory diseases and neuromuscular disorders. Tactile Medical serves patients with lymphedema (chronic venous insufficiency, cancer-related lymphedema, and primary lymphedema) and those with conditions including cystic fibrosis and other conditions requiring mucus clearance. The company emphasizes clinical evidence, patient education, and at-home therapy options. Products are designed for use in clinical settings and home environments, with emphasis on portability, ease of use, and patient quality of life. The company maintains an active patient and clinician education program including webinars and clinical resources.

Medthera Inc. manufactures WalkPort, a supported walk station designed for home-based therapeutic walking and rehabilitation. Founded in 1987 by quadriplegic entrepreneur Alan Tholkes (who previously founded Altimate Medical and created the EasyStand standing device), Medthera focuses on enabling safe, assisted walking for individuals with mobility limitations due to stroke, spinal cord injury, multiple sclerosis, Parkinson's disease, and other neurological conditions. WalkPort features adjustable knee and foot supports, motorized leg movement assistance, and a contoured padded seating system that allows users to perform gait training independently at home. The device emphasizes ease of use with single-adjustment setup, no-tool assembly, and smooth sit-to-stand transitions with minimal shear force. The product integrates a companion mobile app for progress tracking (steps, pace, duration) with real-time avatar feedback. WalkPort is positioned as a bridge-gap rehabilitation tool that enables locomotor training principles and capitalizes on compliance-intensive home therapy. Clinical validation includes testimonials from spinal cord injury patients, stroke survivors, and licensed physical therapists. The device targets both independent users and those requiring caregiver assistance, accommodating a spectrum from cane/walker users to those needing full standing support. Medthera operates a direct-to-consumer reservation and purchase model with tiered delivery options including white-glove service. The company emphasizes the neurological and psychological benefits of walking—strength building, circulation improvement, joint health support, and mood enhancement—positioning WalkPort within the broader wellness and chronic condition management market.

Kneewell is an FDA-registered, patented medical device designed to help total knee replacement (TKA) and knee contracture patients recover faster by achieving greater knee extension with reduced pain. The device employs three-point Static Progressive Stretch (SPS) therapy principles, enabling patients to augment in-person physical therapy sessions from home. Its bilateral, adjustable design accommodates patients of all sizes, with patient-controlled ratchet mechanism for stretch intensity regulation. The device features a quick-release mechanism for ease of use and is assigned HCPCS code E1811, making it eligible for third-party reimbursement. Kneewell is distributed through a network of partner surgeons, physical therapists, and clinical providers, offering healthcare professionals a research-backed adjunctive therapy tool to improve post-operative knee surgery outcomes.

U Deliver Medical manufactures and distributes tube feeding supplies and accessories designed specifically for home tube feeding patients. The company's core product line includes the Bolee Bag (a specialized feeding bag system) and Bolink caps (Bolink D Cap and Bolink Small Cap), which are designed to simplify enteral nutrition delivery for patients and caregivers in home settings. The company also supplies ENFit O-ring syringes and related accessories. U Deliver Medical positions itself as a provider of feeding tube solutions that address the practical needs of home tube feeders, emphasizing ease of use, faster administration, and improved patient/caregiver experience compared to hospital-designed alternatives. The company operates a direct-to-consumer e-commerce platform and accepts online orders with emphasis on fast shipping and customer support. Primary market is home-based enteral nutrition patients and their caregivers, including pediatric tube feeding families.

Lifestyle Medical Group (LMG) is a US-based manufacturer of medical-grade compression garments with 60 years of combined compression therapy and manufacturing experience. The company specializes in compression legwear, diabetic socks, orthopedic sleeves, and braces designed for pain and swelling relief across the ankle, foot, calf, knee, and wrist. LMG's flagship innovation is SmoothToe™ knitting technology, which orients sock material parallel to toes to eliminate irritation and allow unimpeded toe movement. All products feature multi-level compression zones (15–20 mmHg moderate and 20–30 mmHg prescription levels), 4-way stretch construction, non-binding compression-free toe areas, and form-fitting reciprocated heels with tall top bands to eliminate constriction. Garments are manufactured individually with ultra-soft US-sourced fibers and advanced weaving technologies to improve blood flow and promote healing. The company serves both direct retail and B2B channels, including private-label/white-label opportunities for healthcare providers, retailers, and distributors. All products are medical-grade compression therapy devices suitable for home and clinical use.

Xena Therapies manufactures clinically-tested, drug-free cooling and heating therapy products using proprietary phase change material (PCM) technology. Founded in December 2019 and operational since February 2020, the company produces wearable therapeutic devices for pain management, post-surgical recovery, and women's health applications including menopause symptom relief and heat stress mitigation. The product portfolio encompasses three primary brands: ONYX COOL (therapeutic wraps for pain relief and post-surgical recovery), Opal Cool (cooling solutions designed for women across life stages, including motherhood, menopause, and MS management), and WARMMS Therapy (infrared heat therapy for pain management and metabolic enhancement). All products are manufactured in Minnesota and marketed as safer alternatives to traditional ice therapy, eliminating risks of ice burn or frostbite. The 58°F products maintain optimal temperature for approximately one hour; 80°F products for two hours. ONYX COOL products have demonstrated higher patient satisfaction scores and reduced pain medication usage in post-surgical populations. The company holds FDA Class One medical device registration and emphasizes physician recommendation. Products are available through direct e-commerce channels and wholesale distribution. Target markets include healthcare workers, athletes, post-surgical patients, menopausal women, and patients with multiple sclerosis or heat-related conditions.